[CONTRIBUTIONS AND CLINICAL OBSERVATIONS ON THE ETIOPATHOGENESIS AND THERAPY OF LEINER'S DISEASE].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D002179:Candidiasis, Cutaneous; D003182:Complement C5 / Q000172:deficiency; D003873:Dermatitis, Exfoliative; D004358:Drug Therapy; D000081208:Hereditary Complement Deficiency Diseases; D006801:Humans; D007153:Immunologic Deficiency Syndromes; D007223:Infant; D009930:Organic Chemicals
D003182:Complement C5; D009930:Organic Chemicals; C100192:hachimycin; D000324:Adrenocorticotropic Hormone
CORTICOTROPIN, THERAPEUTIC; DRUG THERAPY; ERYTHRODERMA; INFANT; MONILIASIS, CUTANEOUS; TRICHOMYCIN
BEITRAEGE UND KLINISCHE BEOBACHTUNGEN ZUR ATIOPATHOGENESE UND THERAPIE DER LEINERSCHEN KRANKHEIT.